NCT07348341Recruiting
Coronary Laser Atherectomy Registry From an International Taskforce
Source: ClinicalTrials.gov · Last updated 23 Jul 2026
Brief summary (registry, in English)
This study is a prospective, investigator-initiated, multi-center, single arm, observational registry of performance of Excimer Laser Coronary Atherectomy (ELCA) in standard use cases of percutaneous coronary intervention (PCI).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 17 Nov 2025
- Start date
- 20 Jul 2026
- Primary completion date
- 30 Jul 2028
- Lead sponsor
- Ceric Sàrl
- Diseases
- Coronary artery disease
- NCT number
- NCT07348341
What you commit to
- Study type: Observational
- Planned participants: 500
- From 20 Jul 2026 to the primary completion date, 30 Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Allergy to clopidogrel, prasugrel or ticagrelor or non-compliance
- Post- cardiac arrest or haemodynamic instability
Other
- Pregnant or breast feeding
- Unable to give informed consent
- PCI performed without IVCI attempt
- No ELCA use
- Participation in another trial.
Who the study is looking for
- Subjects will be included if all the following criteria are met:
- Age 18 years or over
- Patient willing to be included in the registry
- Patients with stable coronary artery disease or acute coronary syndromes with de-novo or intra-stent restenosis (ISR) coronary lesions suitable to be treated with ELCA
- Non-Crossable with ICI catheter or:
- Crossable with ICI catheter with significant calcium score suggesting need for calcium modification based on IVUS or OCT criteria and/or
- Non-Dilatable with 1:1 NC balloon
- Mandated use of ICI:
- Attempted before use of ELCA or
- Following ELCA and any other calcium modification strategy utilized (to evaluate whether the additional modification demonstrates significant additional modification of the calcium on ICI)
- Final after DES implantation or prior to use of DCB
- Declared PCI strategy (planned use of ELCA, need for IVL/specialty balloons/alternative atherectomy and stent strategy) prior to PCI procedure
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| La Paz Universtity Hospital Coordinator of this site? Confirm its status | Madrid | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.